Obinutuzumab in Chinese Real-world Patients With iNHL

Clinical trial NCT05968001 · UNKNOWN

Trial details

NCT number: NCT05968001
Sponsor: Affiliated Hospital of Nantong University
Status: UNKNOWN
Study type: OBSERVATIONAL

Lymphomas Non-Hodgkin's B-Cell

Start date: 2023-07-20
Primary completion: 2024-12-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.